Skip to main content Skip to navigation

Lecture by Dr Britta Stordal, Middlesex University

BSTitle: Comparative Selection Strategies for Development of Platinum-Drug Resistant Ovarian Cancer Cell Lines
Date: Monday 21 May, 12.30pm-1.30pm
Venue: Oculus OC0.03

Come and join us for free lunch and an interesting talk from Dr Britta Stordal, Senior Lecturer in Life Sciences at Middlesex University London. Her visit is hosted by Professor Peter Sadler.


The development of a drug-resistant cell line in vitro can take from three to 18 months. However, little is published on the methodology of this development process. Clinically relevant drug-resistant cell lines are developed by mimicking the conditions cancer patients experience during chemotherapy. Doses of drug administered are low, and a pulsed treatment strategy is often used where the cells recover in drug-free media. It is common to have difficulty developing stable clinically relevant drug-resistant cell lines. A comparative selection strategy of multiple cell lines or multiple chemotherapeutic agents mitigates this risk and gives insight into which agents or which clinical phenotypes develops resistance easily.


Privacy notice
This form will be used to manage attendance at an event. Your attendance at the event will be recorded and associated with your name, but no other personally identifiable data will be stored, and the data will not be used for any purpose other than as a record of the event.

The University of Warwick is the Data Controller of any information you have entered on this form and is committed to protecting the rights of individuals in line with Data Protection Legislation. The University's Data Protection webpages provide further information on your rights and how the University processes personal data. If you wish to submit a data subjects rights request, make a complaint or report a suspected personal data breach, please contact the University’s Data Protection Officer by email at

Spam prevention

Failure to load reCAPTCHA

reCAPTCHA is a utility used to verify you're not a robot filling out this form. Unfortunately this has failed to load correctly.

Please try reloading the page. If the problem persists, or if you are in a country which blocks Google products, please contact us by using the ‘page contact’ link at the foot of this page.